Dankook University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Jukjeon Korea, Republic of (1947)

Organization Overview

First Clinical Trial
2010
NCT01127100
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dankook University | Dankook University College of Medicine | Dankook University Hospital, Cheonan, Korea | Dankook Univ. Hospotal (31116) 201 Manghyang-ro, Dongnam-gu, Cheonan, Chung Nam, South Korea

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 4)

Coronary Artery Disease (Phase 4)

Hepatitis C (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Neuralgia (Phase 4)

Renal Insufficiency (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 3)

Spinal Stenosis (Phase 4)

Tuberculosis (Phase 2)

Tuberculosis, Multidrug-Resistant (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 19